The Impurities or Metabolites of below APIs or pharmacology tools or positive controls were synthesized and identified in Topharman for R&D purpose.

ABT-724
Adapalene
Adefovir,Tenofovir
Alibendol
Ambrisentan
Antazoline
Aprepitant
Aripiprazole
Armodafinil
Atazanavir
atomoxetine
Atovaqone
Atracurium
Azacitidine
Azasetron

BAY 60-7550
Bicifadine
Bifonazole
BILN-2061
BILR-355
Bortezomib
Bosentan
Bosutinib
Bumetanide
Bupropion

Candesartan
Canertinib
Capecitabine
Carvedilol
CisAtracurium
Choulerine
Clopidogrel
Chlorochoulerine
Clozapine
Cilostazol
CP-226269

Dapoxetine
Decitabine
Delavirdine
DesmethylSertraline
DesmethylVenlaxfacine
Donepezil
Duloxetine

Emtritabine
Entecavir
Erlotinib
Exalamide
Ezetimibe

Fananserin
Fenoxazoline
Flibanserin (BIMT 17)
Fluoxetine
Fluvoxamine
Fluticasone

Gatifloxacin
Gefitinib
Gemcitabine
Gepirone

Imatinib
Imidocarb
Imiquimod
Irbesartan
Isotretinoin

Ketanserin

Leflunomide
LevoCetirizine
Liranaftate
Lofexidine
Loratadine
Lorcaserin

mCPP
Mebevirine
Mebhydroline
Meclizine
Meclofenoxate
Modafinil
Neratinib (HKI-272)
Montelukast

Olmesartan
Orlistat
Oxandrolone

Palonosetron
Pemetrexed

Quetiapin

PD-168077
Pramipexole
Prasugrel
Ramosetrone
Rebamipide
RDEA806
Rimonabant
Rivaroxaban
Rivastigmine
Rizatriptan
Rocuronium
Roflumilast

Saxagliptin
Sertraline
Sibutramine
Sildenafil
SLV-308
Spirapril
Stepholidine
Sumatriptan

Tadalafil
Taltirelin
Telmisartan
Testosterone Decanoate
Testosterone Undecanoate
Tiagabine
Tioconazole
Tolazoline
Trandolapril
Trenbolone
Triclabendazole

Udenafil

Vardenafil
Venlaxfacine
VX-950

WAY-470
WAY-629

Zanamivir
Ziprasidone
Zoledronic Acid
Zonisamide